Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.48 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | DRD4 | P21917 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | HRH2 | P25021 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7330615 | 1.00 | GRIN2B (0.50) | GRIN2BMEN1KMT2AACHEBACE1 | |
| SCHEMBL7323800 | 0.87 | ACHE (0.51) | GRIN2BACHEBACE1DRD2DRD4 | |
| SCHEMBL7323804 | 0.87 | ACHE (0.51) | GRIN2BACHEBACE1DRD2DRD4 | |
| SCHEMBL7322347 | 0.86 | BCHE (0.50) | ACHEBACE1CHRM3 | |
| SCHEMBL467141 | 0.86 | BCHE (0.50) | ACHEBACE1CHRM3 | |
| SCHEMBL467140 | 0.86 | BCHE (0.50) | ACHEBACE1CHRM3 | |
| SCHEMBL467142 | 0.86 | BCHE (0.50) | ACHEBACE1CHRM3 | |
| SCHEMBL7324516 | 0.78 | GRIN2B (0.54) | GRIN2BACHEBACE1 | |
| SCHEMBL7324510 | 0.78 | GRIN2B (0.54) | GRIN2BACHEBACE1 | |
| SCHEMBL240629 | 0.78 | OPRL1 (0.73) | MEN1KMT2ASIGMAR1DRD2DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5532243-A | SIGMA RECEPTOR ANTAGONISTS; SIDE EFFECT REDUCTION | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-07-02 | — | — | US | disclosed |
| EP-0626949-A1 | ANTIPSYCHOTIC NITROGEN-CONTAINING BICYCLIC COMPOUNDS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-12-07 | — | — | EP | disclosed |
| WO-1993016050-A1 | ANTIPSYCHOTIC NITROGEN-CONTAINING BICYCLIC COMPOUNDS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1993-08-19 | — | — | WO | disclosed |